|
gptkbp:instanceOf
|
gptkb:public_company
|
|
gptkbp:acquiredBy
|
gptkb:Advanced_Cell_Diagnostics
gptkb:Asuragen
gptkb:Exosome_Diagnostics
gptkb:ProteinSimple
gptkb:Quad_Technologies
|
|
gptkbp:CEO
|
gptkb:Kim_Kelderman
|
|
gptkbp:division
|
gptkb:Advanced_Cell_Diagnostics
gptkb:Asuragen
gptkb:Exosome_Diagnostics
gptkb:ProteinSimple
gptkb:Amino_Diagnostics
gptkb:B-MoGen_Biotechnologies
gptkb:BiosPacific
gptkb:Boston_Biochem
gptkb:CyVek
gptkb:Lunaphore
gptkb:Namocell
gptkb:Novus_Biologicals
gptkb:PrimeGene
gptkb:Quad_Technologies
gptkb:R&D_Systems
gptkb:Tocris_Bioscience
|
|
gptkbp:formerName
|
gptkb:Techne_Corporation
|
|
gptkbp:founded
|
1976
|
|
gptkbp:founder
|
gptkb:Roger_C._Lucas
|
|
gptkbp:headquarters_location
|
gptkb:Minneapolis,_Minnesota,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bio-Techne Corporation
|
|
gptkbp:industry
|
gptkb:biotechnology
life sciences
|
|
gptkbp:ISIN
|
US09073M1045
|
|
gptkbp:keyPerson
|
gptkb:Kim_Kelderman
gptkb:John_L._Higgins_(Chairman)
Charles R. Kummeth (former CEO)
|
|
gptkbp:marketCap
|
~$12 billion (2023)
|
|
gptkbp:NAICS
|
325413
|
|
gptkbp:numberOfEmployees
|
~2,700
|
|
gptkbp:products
|
instruments
immunoassays
proteins
antibodies
reagents
diagnostic tools
|
|
gptkbp:revenue
|
$1.1 billion (2023)
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:SIC
|
2836
|
|
gptkbp:stockExchange
|
gptkb:NASDAQ
|
|
gptkbp:stockSymbol
|
TECH
|
|
gptkbp:subsidiary
|
gptkb:Advanced_Cell_Diagnostics
gptkb:Asuragen
gptkb:Exosome_Diagnostics
gptkb:ProteinSimple
gptkb:Novus_Biologicals
gptkb:R&D_Systems
gptkb:Tocris_Bioscience
|
|
gptkbp:website
|
https://www.bio-techne.com/
|
|
gptkbp:bfsParent
|
gptkb:^NDX
|
|
gptkbp:bfsLayer
|
6
|